论文部分内容阅读
目的:探究分析异丙托溴铵治疗慢性阻塞性肺病疗效。方法:选取舟山医院自2011年1月-2012年4月收治的慢性阻塞性肺病患者88例,将其随机分为治疗组与对照组,每组均为44例,两组患者均给予规范化常规治疗,包括控制性氧疗、抗感染、抗炎、解痉、平喘、祛痰及对症支持治疗,治疗组在常规治疗外另采取异丙托溴铵气雾剂吸入,观察两组患者治疗后疗效情况及在治疗前后身体各种指标的变化。结果:治疗组治愈患者38例(86.36%)较对照组治愈患者20例(45.45%)多,治疗组患者使用异丙托溴铵治疗后呼吸频率与潮气量有明显好转倾向,对照组无明显好转,P均<0.05,具有统计学意义。结论:对慢性阻塞性肺病患者使用异丙托溴铵治疗具有明显疗效。
Objective: To investigate the efficacy of ipratropium bromide in the treatment of chronic obstructive pulmonary disease. Methods: 88 patients with chronic obstructive pulmonary disease admitted to Zhoushan Hospital from January 2011 to April 2012 were randomly divided into treatment group and control group, with 44 cases in each group. Patients in both groups were given standardization routine The treatment included controlled oxygen therapy, anti-infective, anti-inflammatory, antispasmodic, antiasthmatic, expectorant and symptomatic supportive therapy. The patients in the treatment group received ipratropium bromide aerosol inhalation to observe the treatment of the two groups After the curative effect and before and after treatment of various indicators of body changes. Results: In the treatment group, 38 cases (86.36%) cured more patients than in the control group, 20 cases (45.45%) were more cured. The treatment group had a tendency of respiratory rate and tidal volume after treatment with ipratropium bromide, while the control group had no obvious Improvement, P <0.05, with statistical significance. Conclusions: There is a significant effect of treatment with ipratropium bromide in patients with COPD.